CORTISONE ACETATE

CORTISONE ACETATE was reported 12500 times

CORTISONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 427 0.6392
1 SWOLLEN JOINT COUNT INCREASED 1829 0.5730
2 RHEUMATIC FEVER 2502 0.5607
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3947 0.5503
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1046 0.5222
5 C-REACTIVE PROTEIN 480 0.5178
6 LUPUS VULGARIS 633 0.5024
7 PEMPHIGUS 6238 0.4984
8 RHEUMATOID FACTOR POSITIVE 2850 0.4929
9 DUODENAL ULCER PERFORATION 3523 0.4733
10 FACET JOINT SYNDROME 1417 0.4348
11 HAND DEFORMITY 5218 0.3974
12 HELICOBACTER INFECTION 3537 0.3438
13 SWOLLEN JOINT COUNT 80 0.3200
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 662 0.3192
15 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
16 RETINITIS 502 0.2903
17 DISLOCATION OF VERTEBRA 633 0.2773
18 PERICARDITIS 4551 0.2706
19 HEPATIC ENZYME 40 0.2685
20 MUSCLE INJURY 2217 0.2673
21 X-RAY ABNORMAL 465 0.2598
22 SERONEGATIVE ARTHRITIS 294 0.2565
23 GLOSSODYNIA 5630 0.2512
24 SYNOVITIS 4510 0.2499
25 PERIPHERAL VENOUS DISEASE 980 0.2397
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1531 0.2355
27 FOLLICULITIS 2462 0.2345
28 GRIP STRENGTH 51 0.2227
29 C-REACTIVE PROTEIN ABNORMAL 1325 0.2064
30 HYPOCHOLESTEROLAEMIA 68 0.1926
31 WOUND 5067 0.1811
32 SYSTEMIC LUPUS ERYTHEMATOSUS 6357 0.1789
33 BREAST CANCER STAGE III 1112 0.1715
34 POLYGLANDULAR DISORDER 11 0.1618
35 ONYCHOMADESIS 661 0.1573
36 ANKLE ARTHROPLASTY 56 0.1543
37 LIP DRY 1401 0.1541
38 CONTRAINDICATED PRODUCT ADMINISTERED 4607 0.1520
39 CEREBRAL SALT-WASTING SYNDROME 15 0.1515
40 BONE EROSION 518 0.1463
41 DRUG TOLERANCE DECREASED 402 0.1430
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 15 0.1429
43 NAIL OPERATION 57 0.1377
44 LIVE BIRTH 1107 0.1322
45 JOINT DESTRUCTION 196 0.1260
46 OVERLAP SYNDROME 86 0.1229
47 FEMALE REPRODUCTIVE NEOPLASM 6 0.1224
48 MUSCULOSKELETAL DEFORMITY 28 0.1197
49 GRIP STRENGTH DECREASED 1038 0.1178
50 HYPERCHOLESTEROLAEMIA 1112 0.1151
51 BLEPHAROSPASM 718 0.1139
52 DEATH NEONATAL 157 0.1128
53 ONYCHOMYCOSIS 494 0.1125
54 IRRITABLE BOWEL SYNDROME 2399 0.1118
55 JOINT RANGE OF MOTION DECREASED 1491 0.1111
56 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 62 0.1105
57 AUTOIMMUNE DISORDER 1047 0.1073
58 BURSITIS 1269 0.1045
59 WOUND INFECTION 1125 0.1026
60 RED BLOOD CELL SEDIMENTATION RATE 28 0.1004
61 PORPHYRIA ACUTE 144 0.1003
62 FIBROMYALGIA 2403 0.0987
63 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 75 0.0940
64 LIVER INJURY 2194 0.0893
65 BUNION OPERATION 50 0.0891
66 ARTHROPATHY 4867 0.0875
67 INFUSION SITE REACTION 252 0.0843
68 AORTIC BRUIT 8 0.0833
69 TENDER JOINT COUNT 7 0.0833
70 TYPE 2 DIABETES MELLITUS 2765 0.0820
71 IMPAIRED HEALING 2580 0.0785
72 NAIL DISORDER 687 0.0784
73 OBESITY 1191 0.0747
74 FINGER DEFORMITY 350 0.0722
75 ACQUIRED PORPHYRIA 5 0.0704
76 INFUSION RELATED REACTION 4572 0.0689
77 DISCOMFORT 4085 0.0669
78 HIP ARTHROPLASTY 1013 0.0661
79 SCIATICA 1051 0.0659
80 THERAPEUTIC PRODUCT EFFECT DECREASED 2947 0.0657
81 PSORIATIC ARTHROPATHY 2531 0.0623
82 HEPATIC ENZYME INCREASED 4189 0.0614
83 EXOSTOSIS 558 0.0610
84 FOOT DEFORMITY 662 0.0597
85 SWELLING 5489 0.0586
86 MATERNAL EXPOSURE TIMING UNSPECIFIED 219 0.0582
87 PRESCRIBED OVERDOSE 1123 0.0580
88 ANAEMIA FOLATE DEFICIENCY 11 0.0570
89 LUPUS-LIKE SYNDROME 504 0.0555
90 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 124 0.0538
91 RHEUMATOID ARTHRITIS 6108 0.0537
92 BLOOD CHOLESTEROL INCREASED 2503 0.0536
93 VOCAL CORD OPERATION 5 0.0532
94 LOWER LIMB FRACTURE 1021 0.0531
95 PULMONARY FIBROSIS 992 0.0517
96 SPONDYLITIS 187 0.0514
97 RED BLOOD CELL SEDIMENTATION RATE INCREASED 569 0.0514
98 BACK INJURY 556 0.0511
99 BLISTER 2833 0.0504
100 WALKING AID USER 330 0.0500
101 ANKLE DEFORMITY 16 0.0498
102 PRODUCT LABEL CONFUSION 290 0.0497
103 MATERNAL EXPOSURE DURING PREGNANCY 4426 0.0496
104 LARYNGITIS VIRAL 5 0.0472
105 LOWER RESPIRATORY TRACT INFECTION 2125 0.0467
106 PHARYNGEAL CYST 5 0.0463
107 COELIAC DISEASE 453 0.0461
108 DRUG TOLERANCE 233 0.0460
109 SYNOVIAL FLUID ANALYSIS 4 0.0460
110 EYE INJURY 139 0.0457
111 KNEE ARTHROPLASTY 956 0.0454
112 DRUG INTOLERANCE 4386 0.0454
113 ULCER HAEMORRHAGE 303 0.0447
114 CONGENITAL ANOMALY 343 0.0443
115 GAIT INABILITY 1470 0.0439
116 JOINT DISLOCATION 446 0.0421
117 PRESCRIBED UNDERDOSE 830 0.0416
118 TREATMENT FAILURE 3394 0.0409
119 STOMATITIS 2450 0.0404
120 CARCINOID TUMOUR OF THE SMALL BOWEL 4 0.0385
121 OSTEOARTHRITIS 1613 0.0380
122 NIGHT SWEATS 1211 0.0375
123 JOINT SWELLING 4352 0.0360
124 ABDOMINAL DISCOMFORT 6037 0.0360
125 ANTIPHOSPHOLIPID ANTIBODIES 7 0.0359
126 BLOOD CHOLESTEROL 17 0.0358
127 MALIGNANT GLIOMA 5 0.0352
128 VASCULAR ACCESS COMPLICATION 28 0.0346
129 MEAN PLATELET VOLUME DECREASED 29 0.0346
130 MOBILITY DECREASED 2473 0.0344
131 BREAST CANCER STAGE II 278 0.0334
132 SPINAL FUSION SURGERY 133 0.0328
133 C-REACTIVE PROTEIN INCREASED 1187 0.0326
134 POLYARTHRITIS 170 0.0322
135 ACETABULUM FRACTURE 12 0.0321
136 ILL-DEFINED DISORDER 1904 0.0313
137 WHEEZING 1856 0.0313
138 ALOPECIA 6123 0.0311
139 INJURY 2168 0.0308
140 MUSCULOSKELETAL STIFFNESS 2692 0.0307
141 HEPATIC CIRRHOSIS 575 0.0306
142 PNEUMOCOCCAL INFECTION 18 0.0304
143 LIVER FUNCTION TEST INCREASED 647 0.0301
144 RHEUMATOID NODULE 83 0.0301
145 TASTE DISORDER 589 0.0290
146 LYMPHOCELE 19 0.0286
147 GENERAL PHYSICAL HEALTH DETERIORATION 3218 0.0278
148 OEDEMA 1480 0.0273
149 EPILEPSY 831 0.0272
150 NORMAL NEWBORN 147 0.0270
151 INTENTIONAL PRODUCT USE ISSUE 2351 0.0268
152 ROAD TRAFFIC ACCIDENT 1121 0.0268
153 EXPOSURE DURING PREGNANCY 1655 0.0266
154 SUTURE RUPTURE 18 0.0260
155 INFLAMMATION 1327 0.0257
156 LUNG DISORDER 1242 0.0253
157 PERIPHERAL VEIN THROMBOSIS 6 0.0251
158 WRIST DEFORMITY 15 0.0244
159 PREGNANCY 485 0.0242
160 SLEEP DISORDER 1690 0.0239
161 HYPERSENSITIVITY 4415 0.0238
162 PERFORATION 19 0.0236
163 THERAPY NON-RESPONDER 997 0.0222
164 MUSCULOSKELETAL PAIN 1149 0.0219
165 DRUG-INDUCED LIVER INJURY 673 0.0214
166 LIVER DISORDER 925 0.0208
167 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 348 0.0203
168 GASTROINTESTINAL DISORDER 1809 0.0202
169 FOOT OPERATION 99 0.0200
170 FUNGAL PHARYNGITIS 5 0.0199
171 TREATMENT RELATED SECONDARY MALIGNANCY 4 0.0197
172 ADVERSE REACTION 260 0.0196
173 JOINT STIFFNESS 513 0.0195
174 DELIRIUM 672 0.0193
175 PRODUCT USE ISSUE 3608 0.0192
176 DRY MOUTH 1544 0.0190
177 SINUSITIS 1872 0.0182
178 EAR INFECTION 476 0.0179
179 SYNOVIAL DISORDER 8 0.0176
180 CONTUSION 1687 0.0175
181 MEAN CELL VOLUME DECREASED 27 0.0175
182 GLIOMA 11 0.0171
183 NERVE INJURY 187 0.0168
184 PUSTULAR PSORIASIS 57 0.0166
185 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 4 0.0165
186 SOFT TISSUE DISORDER 18 0.0162
187 INFECTION 2349 0.0162
188 HYPOAESTHESIA 2367 0.0158
189 BRONCHIAL OBSTRUCTION 22 0.0157
190 HYPOPARATHYROIDISM 12 0.0156
191 MEAN CELL HAEMOGLOBIN DECREASED 28 0.0153
192 CONFUSIONAL STATE 2470 0.0153
193 ADRENAL INSUFFICIENCY 185 0.0152
194 DISABILITY 301 0.0152
195 CHRONIC HEPATITIS 12 0.0148
196 STEROID DEPENDENCE 13 0.0148
197 COLONIC STENOSIS 5 0.0145
198 EAR PAIN 282 0.0145
199 HEPATITIS 362 0.0141
200 PERIPHERAL SWELLING 2153 0.0140
201 JOINT SURGERY 6 0.0138
202 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 658 0.0137
203 BLOODY DISCHARGE 15 0.0131
204 HYPERTENSION 2741 0.0129
205 NASOPHARYNGITIS 2384 0.0129
206 PULMONARY CONGESTION 167 0.0127
207 TENOSYNOVITIS STENOSANS 7 0.0126
208 DYSPEPSIA 1235 0.0125
209 OSTEOPOROSIS 505 0.0123
210 RASH VESICULAR 59 0.0122
211 MYCOBACTERIUM CHELONAE INFECTION 9 0.0122
212 CATARRH 11 0.0122
213 MIGRAINE 1161 0.0121
214 WHEELCHAIR USER 54 0.0121
215 URTICARIA 2016 0.0120
216 ADVERSE EVENT 1074 0.0116
217 RASH 5027 0.0115
218 IMMUNODEFICIENCY 169 0.0113
219 ELBOW OPERATION 7 0.0112
220 CONDITION AGGRAVATED 3397 0.0112
221 WEIGHT INCREASED 2386 0.0106
222 LOWER RESPIRATORY TRACT CONGESTION 18 0.0106
223 SUSPECTED OFF LABEL USE 47 0.0104
224 ADVERSE DRUG REACTION 928 0.0103
225 CEREBELLAR STROKE 4 0.0102
226 RESPIRATORY DISORDER 306 0.0102
227 PAIN 6279 0.0102
228 AMNESIA 660 0.0101
229 ENDOCRINE DISORDER 13 0.0101
230 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 720 0.0101
231 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 170 0.0100
232 ASTHMA 1121 0.0099
233 JOINT ARTHROPLASTY 17 0.0095
234 ACROMEGALY 3 0.0095
235 NECK PAIN 527 0.0094
236 MUSCLE SPASTICITY 113 0.0092
237 NODULE 119 0.0091
238 MUSCULAR WEAKNESS 1034 0.0091
239 MEDICATION ERROR 501 0.0090
240 GASTROOESOPHAGEAL REFLUX DISEASE 701 0.0087
241 INJECTION SITE REACTION 589 0.0086
242 ABDOMINAL PAIN UPPER 1749 0.0085
243 ARTHRITIS 666 0.0085
244 ARTHRALGIA 3517 0.0084
245 HYPERTRANSAMINASAEMIA 58 0.0083
246 MEMORY IMPAIRMENT 1119 0.0081
247 PARAESTHESIA 1264 0.0080
248 MONOCYTE COUNT INCREASED 29 0.0080
249 ANAL ABSCESS 40 0.0074
250 FATIGUE 5760 0.0074
251 PRODUCT USE IN UNAPPROVED INDICATION 1828 0.0074
252 UPPER RESPIRATORY TRACT INFECTION 335 0.0072
253 RESPIRATORY TRACT CONGESTION 114 0.0072
254 DECREASED APPETITE 1638 0.0070
255 OEDEMA PERIPHERAL 859 0.0070
256 WEIGHT FLUCTUATION 73 0.0070
257 ONYCHOCLASIS 48 0.0070
258 MYOSITIS 62 0.0069
259 SCLERITIS 11 0.0069
260 GASTROENTERITIS VIRAL 124 0.0069
261 JOINT EFFUSION 47 0.0068
262 INTERNATIONAL NORMALISED RATIO FLUCTUATION 14 0.0068
263 CHEST PAIN 1222 0.0066
264 VENOUS THROMBOSIS LIMB 13 0.0063
265 BURNS SECOND DEGREE 11 0.0063
266 BLOOD CORTISOL DECREASED 4 0.0063
267 TOOTH INFECTION 82 0.0062
268 MUSCLE SPASMS 1123 0.0061
269 FREQUENT BOWEL MOVEMENTS 165 0.0061
270 PYREXIA 2100 0.0061
271 HYPOCALCAEMIA 114 0.0060
272 UNDERDOSE 435 0.0060
273 PAIN IN EXTREMITY 1707 0.0058
274 ALLERGY TO CHEMICALS 7 0.0056
275 ERYSIPELAS 28 0.0056
276 GENERAL SYMPTOM 41 0.0055
277 THERAPEUTIC RESPONSE DECREASED 330 0.0054
278 PHYSICAL DISABILITY 24 0.0054
279 GAIT DISTURBANCE 1039 0.0054
280 CALCINOSIS 12 0.0054
281 CLEFT LIP AND PALATE 6 0.0054
282 ASPARTATE AMINOTRANSFERASE ABNORMAL 8 0.0052
283 INSOMNIA 1390 0.0052
284 LIMB DISCOMFORT 161 0.0052
285 DEPRESSION 1151 0.0051
286 HUNGER 70 0.0050
287 PRURITUS 1920 0.0050
288 ONYCHALGIA 5 0.0050
289 SPONTANEOUS HAEMORRHAGE 5 0.0049
290 ABSCESS JAW 5 0.0048
291 PNEUMONIA 1544 0.0048
292 VOMITING 2229 0.0047
293 NEPHROLITHIASIS 216 0.0047
294 DEFORMITY 44 0.0047
295 DRUG INEFFECTIVE 6195 0.0047
296 VITILIGO 11 0.0047
297 APTYALISM 4 0.0047
298 COLITIS ULCERATIVE 205 0.0046
299 LYME DISEASE 15 0.0045
300 VISUAL IMPAIRMENT 557 0.0045
301 KIDNEY INFECTION 88 0.0045
302 OFF LABEL USE 3919 0.0045
303 MALAISE 1957 0.0045
304 BONE CONTUSION 4 0.0044
305 DYSLEXIA 5 0.0043
306 BRONCHITIS 320 0.0043
307 URINE OUTPUT INCREASED 11 0.0042
308 HEADACHE 2596 0.0041
309 PRODUCT QUALITY ISSUE 562 0.0041
310 DIZZINESS 2056 0.0041
311 ASTHENIA 1537 0.0041
312 FOETAL EXPOSURE DURING PREGNANCY 323 0.0040
313 ABDOMINAL DISTENSION 408 0.0039
314 CORONAVIRUS TEST POSITIVE 4 0.0039
315 BREAST CANCER STAGE I 36 0.0039
316 ABDOMINAL PAIN 903 0.0039
317 DYSPNOEA 2183 0.0039
318 WOUND DEHISCENCE 13 0.0038
319 HYPOKALAEMIA 177 0.0038
320 WHITE BLOOD CELL COUNT INCREASED 147 0.0038
321 RECTAL HAEMORRHAGE 164 0.0038
322 PLATELET COUNT INCREASED 49 0.0038
323 CUSHINGOID 12 0.0037
324 TOOTH DISORDER 83 0.0037
325 PITUITARY TUMOUR BENIGN 6 0.0037
326 EFFUSION 5 0.0037
327 PSORIASIS 477 0.0036
328 BACK DISORDER 59 0.0036
329 POLYNEUROPATHY 43 0.0036
330 SPUTUM DISCOLOURED 34 0.0036
331 OPEN WOUND 4 0.0036
332 IRON DEFICIENCY 16 0.0036
333 MULTIPLE-DRUG RESISTANCE 11 0.0035
334 LABORATORY TEST ABNORMAL 103 0.0035
335 TACHYCARDIA 309 0.0035
336 TONGUE COATED 6 0.0035
337 FUNCTIONAL GASTROINTESTINAL DISORDER 12 0.0035
338 HYPOPNOEA 12 0.0035
339 DIARRHOEA 2199 0.0034
340 SEPTIC SHOCK 148 0.0034
341 LYMPHOMA 52 0.0034
342 ALCOHOL POISONING 9 0.0034
343 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
344 STERNAL FRACTURE 4 0.0032
345 PERIODONTITIS 7 0.0032
346 SINUS HEADACHE 19 0.0032
347 ANXIETY 899 0.0032
348 WEIGHT DECREASED 872 0.0031
349 BODY TEMPERATURE INCREASED 63 0.0031
350 SPINAL DISORDER 29 0.0031
351 ABSCESS LIMB 13 0.0030
352 LYMPHOEDEMA 21 0.0030
353 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
354 PROTEIN TOTAL INCREASED 8 0.0030
355 LYMPHOCYTE PERCENTAGE DECREASED 4 0.0030
356 DUODENAL ULCER 21 0.0030
357 SHOULDER ARTHROPLASTY 8 0.0030
358 BRONCHIECTASIS 20 0.0030
359 NAUSEA 2304 0.0029
360 OSTEONECROSIS OF JAW 72 0.0029
361 PLEURITIC PAIN 8 0.0029
362 PANCREATITIS 151 0.0029
363 BREAST DISCHARGE 5 0.0029
364 STAPHYLOCOCCAL SEPSIS 14 0.0028
365 ASPIRATION 31 0.0028
366 CATAPLEXY 4 0.0028
367 SYNOVIAL CYST 13 0.0028
368 HYPERNATRAEMIA 14 0.0028
369 INTRA-ABDOMINAL FLUID COLLECTION 5 0.0028
370 MATERNAL EXPOSURE BEFORE PREGNANCY 19 0.0028
371 CROHN'S DISEASE 19 0.0028
372 NASAL OEDEMA 5 0.0028
373 CREPITATIONS 8 0.0027
374 CHRONIC SINUSITIS 10 0.0027
375 FEELING HOT 163 0.0027
376 PREGNANCY AFTER POST COITAL CONTRACEPTION 6 0.0027
377 ADHESION 4 0.0026
378 ADRENAL DISORDER 5 0.0026
379 AORTIC STENOSIS 9 0.0026
380 TOOTH LOSS 52 0.0025
381 WEIGHT ABNORMAL 6 0.0025
382 SKIN ATROPHY 14 0.0024
383 COLONIC POLYP 4 0.0024
384 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
385 RASH PRURITIC 128 0.0024
386 RHINITIS 19 0.0024
387 SYMPTOM RECURRENCE 14 0.0023
388 EXOPHTHALMOS 5 0.0023
389 SPONDYLOLISTHESIS 4 0.0023
390 MOVEMENT DISORDER 74 0.0023
391 OLIGURIA 14 0.0023
392 PLEURAL EFFUSION 137 0.0022
393 FLANK PAIN 21 0.0022
394 LEUKOPENIA 110 0.0022
395 CARDIAC MURMUR 19 0.0022
396 READING DISORDER 5 0.0022
397 ESSENTIAL HYPERTENSION 4 0.0022
398 ATRIAL FIBRILLATION 212 0.0022
399 TENOSYNOVITIS 6 0.0022
400 ALCOHOL USE 8 0.0022
401 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
402 ANTINUCLEAR ANTIBODY POSITIVE 7 0.0022
403 TOXIC EPIDERMAL NECROLYSIS 32 0.0021
404 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
405 ULCER 32 0.0020
406 HOSPITALISATION 309 0.0020
407 TREATMENT NONCOMPLIANCE 105 0.0019
408 SKIN REACTION 27 0.0019
409 FLUID RETENTION 97 0.0019
410 INTESTINAL STENOSIS 8 0.0019
411 RENAL CYST 15 0.0019
412 EAR CONGESTION 5 0.0018
413 SPINAL OSTEOARTHRITIS 16 0.0018
414 FEAR OF DEATH 4 0.0018
415 TOOTH ABSCESS 18 0.0018
416 BLOOD COUNT ABNORMAL 26 0.0017
417 THROMBOPHLEBITIS 6 0.0017
418 INCORRECT PRODUCT ADMINISTRATION DURATION 37 0.0017
419 RENAL PAIN 18 0.0017
420 SKIN INFECTION 19 0.0017
421 SECRETION DISCHARGE 21 0.0017
422 ENTEROCOCCAL INFECTION 8 0.0017
423 FOOD INTOLERANCE 6 0.0016
424 EYE OEDEMA 4 0.0016
425 PYELONEPHRITIS 14 0.0016
426 PAROSMIA 12 0.0016
427 OSTEITIS 4 0.0016
428 PATHOLOGICAL FRACTURE 8 0.0016
429 LOSS OF CONSCIOUSNESS 199 0.0016
430 PHARYNGITIS 19 0.0015
431 OTITIS MEDIA 5 0.0015
432 GINGIVAL PAIN 12 0.0015
433 WEIGHT BEARING DIFFICULTY 4 0.0015
434 SEASONAL ALLERGY 21 0.0015
435 EYE INFLAMMATION 14 0.0015
436 ABNORMAL FAECES 12 0.0015
437 HYPERAESTHESIA 12 0.0015
438 BRONCHOPNEUMONIA 5 0.0015
439 GASTROINTESTINAL INFECTION 13 0.0014
440 VITREOUS HAEMORRHAGE 4 0.0014
441 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
442 ABSCESS 23 0.0014
443 THROMBOCYTOPENIA 160 0.0014
444 MUSCULOSKELETAL CHEST PAIN 22 0.0014
445 ANAPHYLACTIC REACTION 78 0.0014
446 RIB FRACTURE 29 0.0014
447 LUMBAR SPINAL STENOSIS 4 0.0014
448 FEELING JITTERY 26 0.0014
449 FALL 450 0.0014
450 THORACIC VERTEBRAL FRACTURE 4 0.0014
451 BLOOD CULTURE POSITIVE 4 0.0013
452 RESPIRATORY TRACT INFECTION 34 0.0013
453 UPPER LIMB FRACTURE 26 0.0013
454 ROSACEA 6 0.0013
455 PRE-EXISTING CONDITION IMPROVED 8 0.0013
456 JAW DISORDER 7 0.0013
457 SKIN ABRASION 6 0.0013
458 OESOPHAGEAL PAIN 5 0.0013
459 TESTICULAR PAIN 4 0.0013
460 ANGIOPATHY 7 0.0012
461 ATELECTASIS 12 0.0012
462 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
463 HEPATIC STEATOSIS 23 0.0012
464 TRIGGER FINGER 5 0.0012
465 FEELING COLD 34 0.0012
466 INFLAMMATORY MARKER INCREASED 6 0.0012
467 CHOLELITHIASIS 39 0.0012
468 IMPAIRED QUALITY OF LIFE 17 0.0012
469 ACCIDENTAL OVERDOSE 43 0.0012
470 INTERVERTEBRAL DISC DISORDER 5 0.0012
471 PURULENT DISCHARGE 5 0.0012
472 IMPAIRED WORK ABILITY 25 0.0012
473 DIABETES MELLITUS 88 0.0012
474 MONOPLEGIA 5 0.0011
475 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
476 RASH ERYTHEMATOUS 54 0.0011
477 RHINITIS ALLERGIC 5 0.0011
478 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
479 SENSITIVE SKIN 8 0.0011
480 FISTULA 12 0.0011
481 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
482 TRANSFUSION 11 0.0010
483 CARDIAC VALVE DISEASE 6 0.0010
484 GASTRIC DISORDER 36 0.0010
485 EJECTION FRACTION DECREASED 16 0.0010
486 POOR QUALITY SLEEP 22 0.0010
487 VENOUS THROMBOSIS 4 0.0010
488 NASAL POLYPS 5 0.0010
489 OVERDOSE 219 0.0010
490 CANDIDA INFECTION 17 0.0010
491 HEPATIC ENZYME ABNORMAL 5 0.0010
492 BONE LOSS 15 0.0010
493 SLEEP APNOEA SYNDROME 19 0.0010
494 BLOOD PRESSURE INCREASED 151 0.0010
495 PRODUCTIVE COUGH 47 0.0010
496 DECUBITUS ULCER 8 0.0010
497 DEMYELINATION 4 0.0010
498 ARTHRITIS BACTERIAL 4 0.0010
499 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
500 LUNG INFECTION 15 0.0010
501 RASH PUSTULAR 7 0.0010
502 TENDERNESS 10 0.0010
503 ABDOMINAL ADHESIONS 3 0.0009
504 HEPATOTOXICITY 21 0.0009
505 AORTIC VALVE INCOMPETENCE 4 0.0009
506 ROTATOR CUFF SYNDROME 12 0.0009
507 HYPOTENSION 186 0.0009
508 MULTI-ORGAN FAILURE 16 0.0009
509 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
510 BLOOD GLUCOSE ABNORMAL 17 0.0009
511 BLOOD PRESSURE FLUCTUATION 22 0.0009
512 NEOPLASM MALIGNANT 61 0.0009
513 MELANOCYTIC NAEVUS 4 0.0009
514 CATHETERISATION CARDIAC 4 0.0009
515 GASTROINTESTINAL INFLAMMATION 7 0.0009
516 URINARY TRACT DISORDER 4 0.0009
517 DYSPNOEA EXERTIONAL 33 0.0009
518 NEUROLOGICAL SYMPTOM 5 0.0009
519 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
520 LUMBAR VERTEBRAL FRACTURE 4 0.0009
521 NERVE COMPRESSION 8 0.0009
522 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
523 RENAL FUNCTION TEST ABNORMAL 4 0.0009
524 METABOLIC DISORDER 5 0.0009
525 POST PROCEDURAL INFECTION 7 0.0009
526 INTRAOCULAR PRESSURE INCREASED 11 0.0009
527 MOUTH ULCERATION 18 0.0009
528 INCONTINENCE 9 0.0009
529 SPINAL COLUMN STENOSIS 4 0.0008
530 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
531 INTENTIONAL PRODUCT MISUSE 74 0.0008
532 BLOOD GLUCOSE FLUCTUATION 9 0.0008
533 SMALL INTESTINAL OBSTRUCTION 10 0.0008
534 BREATH SOUNDS ABNORMAL 4 0.0008
535 TENDON RUPTURE 10 0.0008
536 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
537 CYST 10 0.0008
538 HYDRONEPHROSIS 6 0.0008
539 RASH MACULAR 28 0.0008
540 TENDON PAIN 6 0.0008
541 ECZEMA 41 0.0008
542 BLOOD TEST ABNORMAL 11 0.0008
543 PROCTALGIA 5 0.0008
544 OSTEOMYELITIS 14 0.0008
545 PELVIC FRACTURE 6 0.0008
546 CHOLECYSTITIS 9 0.0008
547 TRICUSPID VALVE INCOMPETENCE 6 0.0008
548 CONJUNCTIVITIS 14 0.0008
549 BLOOD PRESSURE ABNORMAL 15 0.0008
550 PHARYNGOLARYNGEAL PAIN 4 0.0008
551 BACK PAIN 174 0.0007
552 GINGIVITIS 4 0.0007
553 NEURALGIA 18 0.0007
554 DRUG RESISTANCE 19 0.0007
555 FAECALOMA 4 0.0007
556 ECCHYMOSIS 5 0.0007
557 ECONOMIC PROBLEM 11 0.0007
558 HYPERKERATOSIS 4 0.0007
559 COUGH 203 0.0007
560 ACCIDENTAL EXPOSURE 3 0.0007
561 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
562 MACULAR OEDEMA 4 0.0007
563 BODY TEMPERATURE DECREASED 7 0.0007
564 HEPATOCELLULAR INJURY 10 0.0007
565 METASTASIS 5 0.0007
566 SPINAL FRACTURE 14 0.0007
567 STAPHYLOCOCCAL INFECTION 23 0.0007
568 SKIN ULCER 18 0.0007
569 SKIN LESION 19 0.0007
570 THROAT IRRITATION 31 0.0007
571 BLOOD SODIUM DECREASED 13 0.0007
572 MUSCULOSKELETAL DISORDER 13 0.0007
573 LUNG INFILTRATION 6 0.0007
574 ABDOMINAL ABSCESS 3 0.0007
575 CATARACT OPERATION 4 0.0007
576 VENTRICULAR EXTRASYSTOLES 7 0.0007
577 BONE PAIN 39 0.0007
578 ANGINA PECTORIS 19 0.0007
579 ABDOMINAL HERNIA 3 0.0007
580 HAEMATOMA 17 0.0007
581 JOINT INJURY 14 0.0007
582 HEART RATE DECREASED 23 0.0007
583 HAEMATOCHEZIA 36 0.0007
584 GENERALISED OEDEMA 8 0.0006
585 SCOLIOSIS 4 0.0006
586 APHTHOUS ULCER 5 0.0006
587 SKIN LACERATION 7 0.0006
588 MUSCULOSKELETAL DISCOMFORT 11 0.0006
589 ARTERIOSCLEROSIS 6 0.0006
590 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
591 PAIN IN JAW 18 0.0006
592 TOOTH FRACTURE 7 0.0006
593 DEEP VEIN THROMBOSIS 41 0.0006
594 CYSTITIS 20 0.0006
595 ENTERITIS 4 0.0006
596 DYSURIA 23 0.0006
597 INFUSION SITE PAIN 8 0.0006
598 ANOREXIA 8 0.0006
599 GASTROENTERITIS 9 0.0006
600 DIVERTICULITIS 17 0.0006
601 HEPATOMEGALY 6 0.0006
602 HYPOGAMMAGLOBULINAEMIA 4 0.0006
603 VERTIGO 37 0.0006
604 ANKYLOSING SPONDYLITIS 8 0.0006
605 RESTLESS LEGS SYNDROME 11 0.0006
606 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
607 ABDOMINAL TENDERNESS 3 0.0006
608 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
609 EMPHYSEMA 6 0.0006
610 POSTOPERATIVE WOUND INFECTION 4 0.0006
611 SINUS CONGESTION 8 0.0006
612 BACTERIAL INFECTION 11 0.0006
613 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
614 PSEUDOMONAS INFECTION 5 0.0006
615 DYSGEUSIA 43 0.0006
616 AUTOIMMUNE HEPATITIS 4 0.0006
617 PETECHIAE 6 0.0006
618 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
619 THERAPEUTIC RESPONSE SHORTENED 19 0.0006
620 BURNING SENSATION 40 0.0006
621 FUNGAL INFECTION 19 0.0006
622 CHEST DISCOMFORT 58 0.0006
623 PULMONARY TOXICITY 4 0.0006
624 PURPURA 5 0.0006
625 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
626 HAND FRACTURE 4 0.0006
627 HAEMORRHOIDS 11 0.0006
628 HYPOTHYROIDISM 18 0.0006
629 ILEUS 7 0.0006
630 DIVERTICULUM 4 0.0006
631 TOOTH EXTRACTION 7 0.0006
632 BODY HEIGHT DECREASED 6 0.0006
633 ANAL INCONTINENCE 5 0.0006
634 TONGUE DISORDER 4 0.0006
635 MUSCLE ATROPHY 7 0.0006
636 OESOPHAGITIS 6 0.0005
637 PATHOGEN RESISTANCE 5 0.0005
638 UTERINE LEIOMYOMA 4 0.0005
639 PALPITATIONS 64 0.0005
640 SWOLLEN TONGUE 17 0.0005
641 RESPIRATORY DISTRESS 15 0.0005
642 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
643 PHOTOPHOBIA 10 0.0005
644 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 29 0.0005
645 SOPOR 7 0.0005
646 RHINORRHOEA 34 0.0005
647 MICTURITION URGENCY 6 0.0005
648 EYE HAEMORRHAGE 7 0.0005
649 TINNITUS 24 0.0005
650 BOWEL MOVEMENT IRREGULARITY 4 0.0005
651 OXYGEN SATURATION DECREASED 29 0.0005
652 PULMONARY OEDEMA 23 0.0005
653 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
654 PERIPHERAL COLDNESS 7 0.0005
655 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
656 SINUS DISORDER 10 0.0005
657 CATARACT 30 0.0005
658 INFLUENZA 56 0.0005
659 WRIST FRACTURE 6 0.0005
660 CARPAL TUNNEL SYNDROME 7 0.0005
661 HAEMORRHAGE 52 0.0005
662 VAGINAL DISCHARGE 5 0.0005
663 MYALGIA 84 0.0005
664 MUSCLE DISORDER 4 0.0005
665 BONE DISORDER 9 0.0005
666 MUSCLE TIGHTNESS 8 0.0005
667 NASAL CONGESTION 29 0.0005
668 AGITATION 36 0.0005
669 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
670 ARRHYTHMIA 23 0.0005
671 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
672 FEMUR FRACTURE 15 0.0005
673 HYPOKINESIA 7 0.0005
674 APATHY 7 0.0005
675 DYSSTASIA 14 0.0005
676 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
677 SCRATCH 5 0.0005
678 EATING DISORDER 10 0.0005
679 DRUG PRESCRIBING ERROR 9 0.0005
680 BLOOD PRESSURE DECREASED 31 0.0005
681 HYPERGLYCAEMIA 17 0.0005
682 SKIN HYPERPIGMENTATION 4 0.0005
683 BLOOD MAGNESIUM DECREASED 4 0.0005
684 MUSCLE STRAIN 4 0.0005
685 ORAL HERPES 9 0.0005
686 NEOPLASM PROGRESSION 16 0.0005
687 BEDRIDDEN 6 0.0005
688 GASTRITIS 12 0.0005
689 PHARYNGEAL OEDEMA 7 0.0005
690 FACIAL PAIN 4 0.0004
691 MALIGNANT MELANOMA 6 0.0004
692 QUALITY OF LIFE DECREASED 6 0.0004
693 GOUT 8 0.0004
694 HEAVY MENSTRUAL BLEEDING 4 0.0004
695 BONE MARROW FAILURE 9 0.0004
696 BLINDNESS 18 0.0004
697 DISEASE RECURRENCE 21 0.0004
698 URINARY TRACT INFECTION 75 0.0004
699 METABOLIC ACIDOSIS 14 0.0004
700 BRAIN NEOPLASM 4 0.0004
701 HIP FRACTURE 14 0.0004
702 NEOPLASM 5 0.0004
703 GASTRIC HAEMORRHAGE 5 0.0004
704 NIGHTMARE 15 0.0004
705 DIARRHOEA HAEMORRHAGIC 4 0.0004
706 OSTEONECROSIS 14 0.0004
707 BLINDNESS UNILATERAL 6 0.0004
708 LACERATION 4 0.0004
709 HEART RATE INCREASED 42 0.0004
710 DIALYSIS 6 0.0004
711 FOOT FRACTURE 8 0.0004
712 BLOOD IRON DECREASED 5 0.0004
713 GASTRIC ULCER 8 0.0004
714 RED BLOOD CELL COUNT DECREASED 12 0.0004
715 HYPERLIPIDAEMIA 5 0.0004
716 POST PROCEDURAL COMPLICATION 8 0.0004
717 INJECTION SITE HAEMATOMA 6 0.0004
718 NOCTURIA 5 0.0004
719 SCHIZOPHRENIA 5 0.0004
720 SURGERY 24 0.0004
721 CARDIOMEGALY 5 0.0004
722 CARDIOMYOPATHY 6 0.0004
723 ABASIA 10 0.0004
724 LIGAMENT SPRAIN 4 0.0004
725 PNEUMONITIS 11 0.0004
726 HAEMATOCRIT DECREASED 8 0.0004
727 INJECTION SITE DISCOLOURATION 5 0.0004
728 OVARIAN CYST 4 0.0004
729 METASTASES TO LIVER 7 0.0004
730 HYPOAESTHESIA ORAL 6 0.0004
731 POISONING 5 0.0004
732 PRODUCT DOSE OMISSION ISSUE 117 0.0004
733 DEPRESSED MOOD 21 0.0004
734 BRAIN OEDEMA 5 0.0004
735 FEEDING DISORDER 8 0.0004
736 MOTOR DYSFUNCTION 4 0.0004
737 EYE PAIN 22 0.0004
738 THYROID DISORDER 6 0.0004
739 EPISTAXIS 29 0.0004
740 ANKLE FRACTURE 6 0.0004
741 TENDONITIS 6 0.0004
742 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
743 TOOTHACHE 7 0.0004
744 NO ADVERSE EVENT 70 0.0004
745 ACUTE MYELOID LEUKAEMIA 6 0.0004
746 ANGER 13 0.0004
747 DERMATITIS 8 0.0004
748 CYANOSIS 6 0.0004
749 DYSPHONIA 22 0.0004
750 SENSORY DISTURBANCE 6 0.0004
751 THROMBOSIS 30 0.0004
752 PSYCHOTIC DISORDER 11 0.0004
753 SKIN DISCOLOURATION 17 0.0004
754 UVEITIS 5 0.0004
755 PULMONARY EMBOLISM 35 0.0004
756 LIMB INJURY 10 0.0004
757 SKIN EXFOLIATION 31 0.0004
758 OROPHARYNGEAL PAIN 34 0.0004
759 BLOOD POTASSIUM DECREASED 11 0.0004
760 GLAUCOMA 7 0.0004
761 HERNIA 7 0.0004
762 DENTAL CARIES 4 0.0004
763 PROSTATE CANCER 29 0.0004
764 HAEMOPTYSIS 10 0.0004
765 OCULAR HYPERAEMIA 17 0.0004
766 DRUG EFFECT INCOMPLETE 13 0.0004
767 MALNUTRITION 4 0.0004
768 BLOOD GLUCOSE INCREASED 67 0.0004
769 EYE INFECTION 4 0.0004
770 MYOCARDIAL ISCHAEMIA 4 0.0004
771 DERMATITIS CONTACT 4 0.0004
772 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
773 SCAR 6 0.0004
774 ANAPHYLACTIC SHOCK 9 0.0003
775 HEAD INJURY 11 0.0003
776 PLATELET COUNT DECREASED 37 0.0003
777 MENTAL DISORDER 15 0.0003
778 MUCOSAL INFLAMMATION 9 0.0003
779 NEEDLE ISSUE 10 0.0003
780 SEPSIS 38 0.0003
781 ANGIOEDEMA 15 0.0003
782 ISCHAEMIC STROKE 6 0.0003
783 COMA 16 0.0003
784 PULMONARY MASS 5 0.0003
785 ACCIDENT 4 0.0003
786 EYE DISORDER 11 0.0003
787 HYPERHIDROSIS 43 0.0003
788 INTERSTITIAL LUNG DISEASE 16 0.0003
789 OSTEOPENIA 5 0.0003
790 COVID-19 57 0.0003
791 SPINAL OPERATION 4 0.0003
792 DEATH 278 0.0003
793 MIDDLE INSOMNIA 6 0.0003
794 AGEUSIA 8 0.0003
795 DRY EYE 16 0.0003
796 DERMATITIS ALLERGIC 4 0.0003
797 SOMNOLENCE 64 0.0003
798 INTENTIONAL DOSE OMISSION 9 0.0003
799 HYPOPHAGIA 8 0.0003
800 ACUTE RESPIRATORY FAILURE 6 0.0003
801 LIVER FUNCTION TEST ABNORMAL 9 0.0003
802 HIATUS HERNIA 4 0.0003
803 BLOOD POTASSIUM INCREASED 5 0.0003
804 SWELLING FACE 20 0.0003
805 DEAFNESS 8 0.0003
806 ORAL CANDIDIASIS 4 0.0003
807 INFLUENZA LIKE ILLNESS 25 0.0003
808 MUSCLE TWITCHING 7 0.0003
809 IMMUNE SYSTEM DISORDER 4 0.0003
810 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
811 HYPONATRAEMIA 17 0.0003
812 ILLNESS 31 0.0003
813 COGNITIVE DISORDER 14 0.0003
814 CARDIAC DISORDER 28 0.0003
815 FEAR 8 0.0003
816 DRUG EFFECT DECREASED 16 0.0003
817 ERYTHEMA 61 0.0003
818 MULTIPLE SCLEROSIS 14 0.0003
819 HYPOGLYCAEMIA 14 0.0003
820 NERVOUS SYSTEM DISORDER 9 0.0003
821 PRESYNCOPE 7 0.0003
822 NERVOUSNESS 15 0.0003
823 MASS 4 0.0003
824 LYMPHOCYTE COUNT DECREASED 5 0.0003
825 BRADYCARDIA 15 0.0003
826 RETCHING 6 0.0003
827 PARALYSIS 4 0.0003
828 HALLUCINATION 21 0.0003
829 FAECES DISCOLOURED 6 0.0003
830 LEUKOCYTOSIS 5 0.0003
831 PELVIC PAIN 5 0.0003
832 VIRAL INFECTION 9 0.0003
833 SKIN HAEMORRHAGE 4 0.0003
834 STEVENS-JOHNSON SYNDROME 6 0.0003
835 TRANSAMINASES INCREASED 6 0.0003
836 SKIN DISORDER 9 0.0003
837 URINARY RETENTION 9 0.0003
838 DIPLOPIA 7 0.0003
839 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
840 BALANCE DISORDER 23 0.0003
841 DRUG INTERACTION 42 0.0003
842 FRACTURE 5 0.0003
843 COLITIS 10 0.0003
844 BLOOD URINE PRESENT 5 0.0003
845 DEVICE RELATED INFECTION 4 0.0003
846 SYNCOPE 26 0.0003
847 RENAL FAILURE ACUTE 11 0.0003
848 CELLULITIS 13 0.0003
849 RENAL DISORDER 12 0.0003
850 DELUSION 4 0.0003
851 HYPERKALAEMIA 9 0.0003
852 BASAL CELL CARCINOMA 4 0.0003
853 BRAIN FOG 4 0.0003
854 DEHYDRATION 34 0.0003
855 HAEMOGLOBIN DECREASED 26 0.0003
856 DYSPHAGIA 24 0.0003
857 PNEUMOTHORAX 4 0.0003
858 SUICIDAL IDEATION 23 0.0003
859 MOOD SWINGS 8 0.0003
860 LOCALISED INFECTION 6 0.0002
861 CHILLS 29 0.0002
862 CEREBRAL INFARCTION 6 0.0002
863 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
864 METASTASES TO BONE 4 0.0002
865 INJECTION SITE WARMTH 5 0.0002
866 VISUAL ACUITY REDUCED 8 0.0002
867 PULMONARY HYPERTENSION 5 0.0002
868 INTENTIONAL DRUG MISUSE 5 0.0002
869 EYE PRURITUS 8 0.0002
870 FACE OEDEMA 4 0.0002
871 CARDIOVASCULAR DISORDER 6 0.0002
872 CIRCULATORY COLLAPSE 4 0.0002
873 VISION BLURRED 32 0.0002
874 HEPATIC FAILURE 7 0.0002
875 PARANOIA 4 0.0002
876 PRURITUS GENERALISED 5 0.0002
877 VAGINAL HAEMORRHAGE 10 0.0002
878 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
879 INJECTION SITE RASH 7 0.0002
880 DISORIENTATION 9 0.0002
881 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
882 HERPES ZOSTER 13 0.0002
883 LYMPHADENOPATHY 8 0.0002
884 HEAD DISCOMFORT 4 0.0002
885 RASH MACULO-PAPULAR 5 0.0002
886 GALLBLADDER DISORDER 4 0.0002
887 CEREBRAL HAEMORRHAGE 8 0.0002
888 RASH PAPULAR 5 0.0002
889 SNEEZING 5 0.0002
890 BLOOD BILIRUBIN INCREASED 6 0.0002
891 NEUROPATHY PERIPHERAL 21 0.0002
892 PERICARDIAL EFFUSION 5 0.0002
893 IRRITABILITY 13 0.0002
894 POLLAKIURIA 9 0.0002
895 CONSTIPATION 47 0.0002
896 FEELING ABNORMAL 51 0.0002
897 CEREBROVASCULAR ACCIDENT 36 0.0002
898 ANAEMIA 40 0.0002
899 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
900 ERUCTATION 4 0.0002
901 CHOKING 4 0.0002
902 BREAST CANCER 19 0.0002
903 ACUTE MYOCARDIAL INFARCTION 6 0.0002
904 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
905 INJECTION SITE PAIN 62 0.0002
906 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
907 BLOOD CREATININE INCREASED 13 0.0002
908 APHASIA 6 0.0002
909 LACRIMATION INCREASED 6 0.0002
910 CORONARY ARTERY DISEASE 6 0.0002
911 ABDOMINAL PAIN LOWER 5 0.0002
912 FLUSHING 20 0.0002
913 INJECTION SITE SWELLING 15 0.0002
914 DRUG ADMINISTRATION ERROR 6 0.0002
915 ERECTILE DYSFUNCTION 5 0.0002
916 FLATULENCE 11 0.0002
917 PERITONITIS 4 0.0002
918 PANIC ATTACK 7 0.0002
919 BONE DENSITY DECREASED 6 0.0002
920 EYE IRRITATION 11 0.0002
921 HALLUCINATION, VISUAL 4 0.0002
922 BLOOD GLUCOSE DECREASED 9 0.0002
923 DYSARTHRIA 7 0.0002
924 SKIN CANCER 4 0.0002
925 ACNE 14 0.0002
926 RESPIRATORY ARREST 5 0.0002
927 TREMOR 30 0.0002
928 PROCEDURAL PAIN 5 0.0002
929 DEMENTIA 5 0.0002
930 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
931 HEART RATE IRREGULAR 4 0.0002
932 PRODUCT AVAILABILITY ISSUE 4 0.0002
933 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
934 CONVULSION 10 0.0002
935 HYPOXIA 6 0.0002
936 URINARY INCONTINENCE 5 0.0002
937 RHABDOMYOLYSIS 7 0.0002
938 RENAL IMPAIRMENT 14 0.0002
939 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
940 SEIZURE 19 0.0002
941 INJECTION SITE URTICARIA 4 0.0002
942 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
943 EYE SWELLING 6 0.0002
944 INJECTION SITE ERYTHEMA 20 0.0002
945 HOT FLUSH 12 0.0002
946 PRODUCT COMPLAINT 4 0.0002
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
948 RASH GENERALISED 4 0.0002
949 ANHEDONIA 4 0.0002
950 RENAL FAILURE 20 0.0002
951 ABORTION SPONTANEOUS 6 0.0001
952 INJECTION SITE PRURITUS 10 0.0001
953 DISTURBANCE IN ATTENTION 8 0.0001
954 NEUTROPENIA 20 0.0001
955 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
956 AGGRESSION 7 0.0001
957 RESPIRATORY FAILURE 10 0.0001
958 CARDIAC FAILURE 11 0.0001
959 CARDIAC FAILURE CONGESTIVE 11 0.0001
960 RESTLESSNESS 5 0.0001
961 CARDIAC ARREST 11 0.0001
962 DERMATITIS ATOPIC 7 0.0001
963 INTESTINAL OBSTRUCTION 5 0.0001
964 MYOCARDIAL INFARCTION 23 0.0001
965 DEPENDENCE 7 0.0001
966 DRY SKIN 17 0.0001
967 ABNORMAL BEHAVIOUR 5 0.0001
968 INJECTION SITE BRUISING 10 0.0001
969 PANCYTOPENIA 7 0.0001
970 DYSKINESIA 5 0.0001
971 WITHDRAWAL SYNDROME 5 0.0001
972 DRUG WITHDRAWAL SYNDROME 10 0.0001
973 INCORRECT DOSE ADMINISTERED 26 0.0001
974 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
975 ABNORMAL DREAMS 3 0.0001
976 DRUG ABUSE 9 0.0001
977 UNEVALUABLE EVENT 8 0.0001
978 FEBRILE NEUTROPENIA 7 0.0001
979 EMOTIONAL DISTRESS 12 0.0001
980 SPEECH DISORDER 5 0.0001
981 INJECTION SITE HAEMORRHAGE 7 0.0001
982 LETHARGY 5 0.0001
983 COMPLETED SUICIDE 7 0.0001
984 TOXICITY TO VARIOUS AGENTS 12 0.0001
985 DRUG DEPENDENCE 11 0.0001
986 DEVICE ISSUE 6 0.0001
987 DRUG DOSE OMISSION 11 0.0001
988 SUICIDE ATTEMPT 4 0.0001
989 CHRONIC KIDNEY DISEASE 5 0.0001
990 PRODUCT DOSE OMISSION 4 0.0001
991 ACUTE KIDNEY INJURY 9 0.0001
992 DISEASE PROGRESSION 6 0.0001
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000